1. Home
  2. PACK vs DCTH Comparison

PACK vs DCTH Comparison

Compare PACK & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PACK
  • DCTH
  • Stock Information
  • Founded
  • PACK 1972
  • DCTH 1988
  • Country
  • PACK United States
  • DCTH United States
  • Employees
  • PACK N/A
  • DCTH N/A
  • Industry
  • PACK Containers/Packaging
  • DCTH Medical/Dental Instruments
  • Sector
  • PACK Consumer Discretionary
  • DCTH Health Care
  • Exchange
  • PACK Nasdaq
  • DCTH Nasdaq
  • Market Cap
  • PACK 445.5M
  • DCTH 388.3M
  • IPO Year
  • PACK N/A
  • DCTH N/A
  • Fundamental
  • Price
  • PACK $4.69
  • DCTH $10.84
  • Analyst Decision
  • PACK Buy
  • DCTH Strong Buy
  • Analyst Count
  • PACK 3
  • DCTH 4
  • Target Price
  • PACK $7.17
  • DCTH $24.50
  • AVG Volume (30 Days)
  • PACK 1.2M
  • DCTH 473.5K
  • Earning Date
  • PACK 10-30-2025
  • DCTH 11-07-2025
  • Dividend Yield
  • PACK N/A
  • DCTH N/A
  • EPS Growth
  • PACK N/A
  • DCTH N/A
  • EPS
  • PACK N/A
  • DCTH 0.06
  • Revenue
  • PACK $380,700,000.00
  • DCTH $70,240,000.00
  • Revenue This Year
  • PACK $10.14
  • DCTH $159.22
  • Revenue Next Year
  • PACK $7.92
  • DCTH $41.22
  • P/E Ratio
  • PACK N/A
  • DCTH $193.39
  • Revenue Growth
  • PACK 10.38
  • DCTH 491.35
  • 52 Week Low
  • PACK $2.91
  • DCTH $8.08
  • 52 Week High
  • PACK $8.70
  • DCTH $18.23
  • Technical
  • Relative Strength Index (RSI)
  • PACK 50.62
  • DCTH 45.67
  • Support Level
  • PACK $4.69
  • DCTH $11.01
  • Resistance Level
  • PACK $4.94
  • DCTH $11.93
  • Average True Range (ATR)
  • PACK 0.35
  • DCTH 0.44
  • MACD
  • PACK -0.06
  • DCTH 0.05
  • Stochastic Oscillator
  • PACK 15.18
  • DCTH 18.05

About PACK Ranpak Holdings Corp

Ranpak Holdings Corp is a provider of environmentally sustainable, systems-based, product protection solutions for e-Commerce and industrial supply chains. The company offers a full suite of protective packaging systems and paper consumables. Geographically, it derives a majority of its revenue from Europe/Asia. The group generates revenue by providing its PPS systems and paper consumables to customers, which include direct end-users and a network of exclusive paper packaging solution distributors, and by providing end-of-line automation systems that solve challenges, including optimization, customization, and efficiency. It has two segments, North America and Europe/Asia.

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

Share on Social Networks: